The Model Context Protocol (MCP) is now available to help Medi-Span’s AI-enabled experts use curated drug data to support the development of AI agents.
Wolters Kluwer Health today announced plans for Medi-Span® Expert AI, designed to provide drug intelligence from Medi-Span for digital health technology developers. Medi-Span, from the makers of UpToDate®, is the leading solution used and trusted across the healthcare ecosystem to optimize users’ medication decisions. Select AI developers can now take advantage of MCP Server, which is designed to reduce development timelines and complexity for customers by connecting third-party AI applications and agents to AI-enabled Medi-Span content.
“AI-powered agency workflows, from prescription renewals to hospital medication verification, are the fastest growing segment in healthcare,” he said. Christopher SullivanVice President and General Manager of Pharmacy and Medical Technology Solutions. “Medi-Span Expert AI is designed to go beyond standard content delivery for agents and serve as the foundational intelligence for a customer’s entire drug usage lifecycle. From raw customer data to autonomous agents, we expect this new evolution to help health tech leaders manage complex workflows, deliver AI-enabled content to customers via MCPs, and help users improve drug decisions by optimizing patient safety solutions.”
MCP leverages content curated by Medi-Span’s AI-enabled experts
Digital health technology companies are rapidly developing agent AI workflows to meet clinical demand for medication management automation. Healthcare providers and pharmacists want faster, clearer, and more consistent support from the systems they trust. Currently, existing integration standards for drug information, such as APIs and flat files, are not optimized for agent AI workflows and can slow down AI-driven innovation. Today, Medi-Span’s MCP Server connects expert-curated pharmaceutical content to workflows in a fast, dynamic format that is ready for use by AI agents. For digital health technology developers, MCP Server helps accelerate time to innovation while providing a robust ecosystem of validated drug content, drug dosing guardrails, and advanced decision logic.
Medi-Span Expert AI introduces AI-enabled features
Wolters Kluwer Health plans to expand its Medi-Span Expert AI solution for use in a range of AI clinical, patient, and administrative workflows. Potential applications span the continuum of healthcare, including clinical decision support, medication order validation/validation, drug search and matching, adverse event monitoring, formulation and benefits management, pricing and contracting, inventory and supply chain optimization.
“Wolters Kluwer understands both the technology and patient care aspects of healthcare. Working with Wolters Kluwer gives us access to evidence-based content backed by over 30 years of knowledge and experience, combined with a robust AI architecture,” said Jean-Claude Saghbini, Chief Technology Officer and President of Technology Services at Lumeris.
